Articles |
 Page 1 of 21  |
Company reports results of ENT-103 expanded preclinical testing.
March 31, 2004
|
U.S. Army Corps of Engineers awards contract to supply hyperbaric cham...
March 31, 2004
|
Assets of biotech firm involved in immune regulation, hepatitis acquir...
March 31, 2004
|
ACT adherence low for pediatric patients in Zambia.
March 31, 2004
|
Biosciences company reports $6.2M private equity placement.
March 31, 2004
|
Clinicians need better tools for identifying people at risk for fractu...
March 31, 2004
|
Children with nephrotic syndrome have adequate response to influenza v...
March 31, 2004
|
Chief financial officer John McCarthy leaves genomics firm.
March 31, 2004
|
FDA clears new biologic bone paste.
March 31, 2004
|
Collection of functional gene knockouts in a multicellular organism pu...
March 31, 2004
|
Genomics company appoints financial expert to board of directors.
March 31, 2004
|
CatchMabs enters commercial bacteriophage production collaboration.
March 31, 2004
|
Macugen data presented at Aspen Retinal Detachment Society meeting.
March 31, 2004
|
Expression of exogenous genes in Trypanosoma cruzi improved.
March 31, 2004
|
IL-12 enhances immunity of Schistosoma mansoni fatty acid-binding prot...
March 31, 2004
|
Lipid peroxidation decreased in patients with rheumatoid arthritis.
March 31, 2004
|
Close postoperative follow-up is needed following colorectal cancer re...
March 31, 2004
|
Misonix to distribute prostate cancer product in Europe.
March 31, 2004
|
Emtricitabine is option for once-daily antiretroviral therapy.
March 31, 2004
|
N,N'-spacer-linked oligomeric ergolines have antimalarial activity.
March 31, 2004
|
Congenital Trypanosoma cruzi abounds in Bolivia despite reduced povert...
March 31, 2004
|
Invacare acquires California seating-products maker.
March 31, 2004
|
Human TT virus variants may be associated with pathology.
March 31, 2004
|
Panel discusses new "before-onset care" paradigm.
March 31, 2004
|
Company presents ATryn safety and efficacy data.
March 31, 2004
|
Andrew M. Clarkson and J. Kenneth Glass join board of men's health com...
March 31, 2004
|
Long-term chemotherapy in children with NHL adversely affects teeth.
March 31, 2004
|
DNA-test provider appoints experts to its medical advisory board.
March 31, 2004
|
Promising new trial investigates colorectal cancer.
March 31, 2004
|
Biotech board approves conditional stock split.
March 31, 2004
|
Early treatment confirmed as key to stroke recovery.
March 31, 2004
|
Factors linked to TB clustering in Spain identified.
March 31, 2004
|
Antibodies to tick salivary antigens detected in patients from Spain.
March 31, 2004
|
Drug-delivery company raises $1.764 million through private placements...
March 31, 2004
|
Head-and-neck cancer study to advance commercialization of the MedPuls...
March 31, 2004
|
Immunotherapy company announces net losses for quarter, year.
March 31, 2004
|
Factive maker reports net losses for fourth quarter and fiscal year 20...
March 31, 2004
|
CXCR4 mediates gp120 neurotoxicity in cerebellar granule cells.
March 31, 2004
|
MMP-9 gene changes associate with bone mineral density in men but not ...
March 31, 2004
|
CD4+CD25+ T[subscript]R cells control anti-HIV, CMV T-cell activity.
March 31, 2004
|
Novel arylsulfonamides active against drug-resistant HIV.
March 31, 2004
|
Off-label use of drug gives children relief.
March 31, 2004
|
Maxxon announces worldwide marketing and distribution agreement.
March 31, 2004
|
Glycoprotein company makes development appointment, opens new office.
March 31, 2004
|
Report: Coating technology is a key in the growth of the medical devic...
March 31, 2004
|
Analysis from TACTICS-TIMI 18 trial published.
March 31, 2004
|
New drug application submitted for Sanvar IR.
March 31, 2004
|
Effects of class I HLA NK epitopes on haploidentical SCT outcome deter...
March 31, 2004
|
Protein 4.1 deficiency linked to acquired elliptocytosis.
March 31, 2004
|
Company announces nationwide implementation of 3D laser-scanning techn...
March 31, 2004
|
Biotech company reports 28% revenue growth in Q4, 52% for the year.
March 31, 2004
|
Interleukin gene therapy expands options for treating osteoarthritis.
March 31, 2004
|
Endothelial progenitor cells are detected in infantile hemangioma.
March 31, 2004
|
Finasteride adversely affects the early diagnosis of prostate cancer.
March 31, 2004
|
Hypertension-induced cardiac remodeling reviewed.
March 31, 2004
|
Increased use of CT creates concerns about radiation exposure.
March 31, 2004
|
Mediastinal stiffening and chest wall scarring can restrict lung infla...
March 31, 2004
|
Metastasis-associated protein 1 signals prostate cancer progression.
March 31, 2004
|
Missense mutation in PAX9 causes non-syndromic oligodontia.
March 31, 2004
|
New human embryonic cell lines to be made available to researchers.
March 31, 2004
|
TLX1 overexpression indicates a good prognosis for adults with T-cell ...
March 31, 2004
|
FDA authorizes a clinical study with Alferon LDO for HIV.
March 31, 2004
|
Healthcare-products company reports fourth quarter diluted EPS of $0.7...
March 31, 2004
|
Preliminary injunction relating to Tannate 12d S will delay initial sh...
March 31, 2004
|
Prevalence of obesity in southeast Spain increasing.
March 31, 2004
|
Parathyroidectomy is needed to prevent recurrent hyperparathyroidism i...
March 31, 2004
|
Fractures of ceramic bearings in total hip arthroplasty occur infreque...
March 31, 2004
|
Lipoprotein[subscript]a levels respond to life-style changes in obese ...
March 31, 2004
|
Pharmaceutical dosage division transfers operating revenues to joint v...
March 31, 2004
|
HLA-A2-restricted anti-Nef CD8 cell response limited in children.
March 31, 2004
|
Leon E. Rosenberg, MD, joins biopharma's board.
March 31, 2004
|
Chairman enters into prearranged stock trading plan.
March 31, 2004
|
FDA approves generic version of Claritin-D 24-Hour.
March 31, 2004
|
Mechanisms downstream of P2Y[subscript]12 ADP-receptor described.
March 31, 2004
|
Structural features of M. tuberculosis AKmt identified.
March 31, 2004
|
| |
1
